Skip to content

The impact of differences in femoral implant design on the peri-implant bone mineral density, muscle strength, and activity level in total hip replacement surgery

The impact of differences in femoral implant design on the peri-implant bone mineral density, muscle strength, and activity level in total hip replacement surgery - EU-SCT1

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057766
Enrollment
74
Registered
2025-05-03
Start date
2025-04-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis of the hip

Interventions

The Insignia Stem utilizes a tapered wedge geometry for fixation within the proximal femur. A key design feature is its substantial proximal volume aimed at maximizing metaphyseal fill in lateral view

Sponsors

Ehime University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Undergoing primary unilateral or bilateral (simultaneous or staged) Total Hip Arthroplasty (THA) at Ehime University Hospital. 2) Diagnosis of advanced to end-stage osteoarthritis of the hip, confirmed radiographically. 3) Presence of hip pain causing functional limitations in activities of daily living (ADLs). 4) Suitable candidacy for either the Insignia Stem or the Accolade II Stem, confirmed by pre-operative CT-based 3D templating. 5) Ability and willingness to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients unable to achieve outdoor ambulation, even with the assistance of walking aids (e.g., canes, walkers). 2) Patients with cognitive impairment precluding informed consent, or those otherwise unable to express intention to participate; additionally, any patient deemed unsuitable for study inclusion by the principal investigator or sub-investigators. 3) Patients diagnosed with osteoarthritis of the hip secondary to infection or trauma, idiopathic osteonecrosis of the femoral head (ONFH), or high-grade developmental dysplasia of the hip (Crowe type III or IV). 4) Patients assessed by the attending physician, based on pre-operative CT planning, as having poor suitability for femoral implant fixation due to anatomical or bone quality concerns.

Design outcomes

Primary

MeasureTime frame
The primary outcome is the change in periprosthetic bone mineral density, measured quantitatively at 1, 2, and 5 years postoperatively using bone mineral density testing around the stem. This change will be calculated relative to the bone mineral density around the stem measured on the 7th day after THA surgery, and the effect of differences in stem design on these changes in periprosthetic bone mineral density will be compared between the two groups.

Secondary

MeasureTime frame
Secondary outcomes will compare the two groups regarding the impact of stem design differences on radiological evaluations (plain radiographs and CT scans) and on pre- and post-operative clinical evaluations, including muscle strength, patient-reported outcomes, activity level, and other relevant factors.

Countries

Japan

Contacts

Public ContactTatsuhiko Kutsuna

Ehime University Graduate School of Medicine Department of Orthopaedic Surgery

kutsuna.tatsuhiko.bh@ehime-u.ac.jp0899605343

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026